Bydd prawf NIPT, sef sampl o waed i'w ddadansoddi mewn labordy, yn cael ei ychwanegu at y llwybr sgrinio fel opsiwn ychwanegol i fenywod sy'n derbyn y sgrinio sylfaenol presennol ac sydd wedi cael gwybod bod yna risg o syndrom Down, Edwards neu Patau.
NIPT, a blood sample analysed in a laboratory, will be added to the screening pathway as an additional option for women who accept current primary screening and are assessed as being at higher chance of Down’s, Edwards’ and Patau’s syndrome.